ID   OU-LC-KI
AC   CVCL_DI06
SY   Okayama University-Lung Carcinoma-KI
DR   Wikidata; Q54936758
RX   PubMed=9538136;
RX   PubMed=10213231;
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:06; B*39:01,51:01; C*14:02,03:04; DQB1*03:32;04:02 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=9538136; DOI=10.3892/ijo.12.5.1103;
RA   Takaki T., Hiraki A., Uenaka A., Gomi S., Itoh K., Udono H.,
RA   Shibuya A., Tsuji T., Sekiguchi S., Nakayama E.;
RT   "Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3
RT   peptide recognized by cytotoxic T lymphocytes.";
RL   Int. J. Oncol. 12:1103-1109(1998).
//
RX   PubMed=10213231;
RA   Hiraki A., Kaneshige T., Kiura K., Ueoka H., Yamane H., Tanaka M.,
RA   Harada M.;
RT   "Loss of HLA haplotype in lung cancer cell lines: implications for
RT   immunosurveillance of altered HLA class I/II phenotypes in lung
RT   cancer.";
RL   Clin. Cancer Res. 5:933-936(1999).
//
RX   PubMed=21048114; DOI=10.4049/jimmunol.1000225;
RA   Eikawa S., Ohue Y., Kitaoka K., Aji T., Uenaka A., Oka M.,
RA   Nakayama E.;
RT   "Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to
RT   IL-6- and IL-8-expressing tumors through predominant induction of
RT   CXCR1 by IL-6.";
RL   J. Immunol. 185:6734-6740(2010).
//
RX   PubMed=22109656; DOI=10.1002/ijc.27359;
RA   Ohue Y., Eikawa S., Okazaki N., Mizote Y., Isobe M., Uenaka A.,
RA   Fukuda M., Old L.J., Oka M., Nakayama E.;
RT   "Spontaneous antibody, and CD4 and CD8 T-cell responses against
RT   XAGE-1b (GAGED2a) in non-small cell lung cancer patients.";
RL   Int. J. Cancer 131:E649-E658(2012).
//